Pharmacists are becoming aware of developing countries: expensive medicines offered at lower prices

The pharmaceutical industry is increasingly making life-saving medications affordable in economically weaker regions, as highlighted by the Access to Medicine Foundation's latest index. Over the past twenty years, there has been a shift in priorities, with pharmaceutical companies now taking responsibility for access to medicines in low- and middle-income countries. An example is Gilead's lenacapavir, a new HIV prevention injection, which is being made available at a significantly reduced price for 120 countries. Access to such medications is crucial, especially in South Africa, where millions are affected by HIV. However, challenges remain, including funding cuts that impact education and outreach efforts.